158 related articles for article (PubMed ID: 35577905)
1. Changing causes of death in persons with haematological cancers 1975-2016.
Chen L; Zheng Y; Yu K; Chen S; Wang W; Gale RP; Liu ZX; Liang Y
Leukemia; 2022 Jul; 36(7):1850-1860. PubMed ID: 35577905
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of haematological cancers in Sarawak, Malaysia (1996 to 2015).
Kuan JW; Su AT; Wahab M; Hamdan A; Hashim J; Kiyu A; Ooi CH
BMC Cancer; 2023 Jun; 23(1):563. PubMed ID: 37337159
[TBL] [Abstract][Full Text] [Related]
3. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
[TBL] [Abstract][Full Text] [Related]
4. Biannual report of the Cochrane Haematological Malignancies Group.
Trelle S; Higgins G; Kober T; Engert A
J Natl Cancer Inst; 2004 Aug; 96(15):E2. PubMed ID: 15292394
[No Abstract] [Full Text] [Related]
5. Sex ratios and the risks of haematological malignancies.
Cartwright RA; Gurney KA; Moorman AV
Br J Haematol; 2002 Sep; 118(4):1071-7. PubMed ID: 12199787
[TBL] [Abstract][Full Text] [Related]
6. Distribution pattern and prevalence of haematological cancers among adults in Abakaliki, South-Eastern Nigeria.
Ugwu NI; Okoye AE; Ugwu CN; Iyare FE; Edegbe FO; Ugwu GC; Chukwurah EF; Richard IC; John DO; Nnadozie UU; Nwokwu EU
Niger Postgrad Med J; 2021; 28(4):266-272. PubMed ID: 34850754
[TBL] [Abstract][Full Text] [Related]
7. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
[TBL] [Abstract][Full Text] [Related]
8. Tumor M2-PK levels in haematological malignancies.
Oremek GM; Rox S; Mitrou P; Sapoutzis N; Sauer-Eppel H
Anticancer Res; 2003; 23(2A):1135-8. PubMed ID: 12820361
[TBL] [Abstract][Full Text] [Related]
9. Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia.
Zheng G; Chattopadhyay S; Sud A; Sundquist K; Sundquist J; Försti A; Houlston R; Hemminki A; Hemminki K
Br J Haematol; 2019 Apr; 185(2):232-239. PubMed ID: 30706458
[TBL] [Abstract][Full Text] [Related]
10. Wage-subsidised employment as a result of permanently reduced work capacity in a nationwide cohort of patients diagnosed with haematological malignancies.
Horsboel TA; Nielsen CV; Nielsen B; Andersen NT; De Thurah A
Acta Oncol; 2015 May; 54(5):743-9. PubMed ID: 25752974
[TBL] [Abstract][Full Text] [Related]
11. Estimating the risk of developing secondary hematologic malignancies in patients with T1/T2 prostate cancer undergoing diverse treatment modalities: A large population-based study.
Mo X; Zhou M; Yan H; Chen X; Wang Y
Cancer Med; 2021 Aug; 10(15):5338-5346. PubMed ID: 34189859
[TBL] [Abstract][Full Text] [Related]
12. [Incidence of neoplasms of the hematologic and lymphoreticular systems in Lower Silesia 1972-1985. I. Incidence in the entire region].
Kotlarek-Haus S; Waszkiewicz L; Kin-Dittmann I; Błaczkowska A
Acta Haematol Pol; 1990; 21(2):173-84. PubMed ID: 2131717
[TBL] [Abstract][Full Text] [Related]
13. Serum immunoglobulins in leukaemia and malignant lymphoma.
Solanki RL; Anand VK; Arora HL
J Indian Med Assoc; 1990 Nov; 88(11):305-7. PubMed ID: 2086658
[TBL] [Abstract][Full Text] [Related]
14. Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres.
Pagano L; Fianchi L; Mele L; Girmenia C; Offidani M; Ricci P; Mitra ME; Picardi M; Caramatti C; Piccaluga P; Nosari A; Buelli M; Allione B; Cortelezzi A; Fabbiano F; Milone G; Invernizzi R; Martino B; Masini L; Todeschini G; Cappucci MA; Russo D; Corvatta L; Martino P; Del Favero A
Br J Haematol; 2002 May; 117(2):379-86. PubMed ID: 11972521
[TBL] [Abstract][Full Text] [Related]
15. Negative illness perceptions are related to more fatigue among haematological cancer survivors: a PROFILES study.
Schoormans D; Jansen M; Mols F; Oerlemans S
Acta Oncol; 2020 Aug; 59(8):959-966. PubMed ID: 32412348
[No Abstract] [Full Text] [Related]
16. A comprehensive approach to therapy of haematological malignancies in older patients.
Cordoba R; Eyre TA; Klepin HD; Wildes TM; Goede V
Lancet Haematol; 2021 Nov; 8(11):e840-e852. PubMed ID: 34624238
[TBL] [Abstract][Full Text] [Related]
17. Living with leukaemia.
Elert E
Nature; 2013 Jun; 498(7455):S2-3. PubMed ID: 23803947
[No Abstract] [Full Text] [Related]
18. [Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary, between 1983 and 2012. Analysis of data from a thirty-year period].
Jakó J; Szerafin L; Nagy P
Orv Hetil; 2013 Nov; 154(47):1858-64. PubMed ID: 24240522
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of the miR-124-1 in haematological malignancies.
Wong KY; So CC; Loong F; Chung LP; Lam WW; Liang R; Li GK; Jin DY; Chim CS
PLoS One; 2011 Apr; 6(4):e19027. PubMed ID: 21544199
[TBL] [Abstract][Full Text] [Related]
20. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century.
Pulte D; Jansen L; Brenner H
Blood Cancer J; 2020 May; 10(5):56. PubMed ID: 32404891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
